Home Innovation That Matters

Innovation That Matters

Building a Global ‘Bridge’ for Life Science Innovation – A Chat with Frank Yu, Founder & CEO of Ally Bridge Group

By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) As the globalization of healthcare expands, Frank Yu and his team at Ally Bridge Group continue to differentiate themselves in the market with strategic and fruitful investments, and by boosting growth for life science companies...

Metabomed: A New Venture in Israel’s Start-Up Ecosystem that Tackles Cancer’s Altered Metabolism – A Chat with Simone Botti, Former Head of Merck Ventures’ Israel BioIncubator and CEO of...

By Hui Cai, Vice President of Corporate Alliances and Head of Communications, WuXi AppTec “We want to understand deeply not only the impact of engaging a target that forms a synthetic lethal pair within the framework of a single cell assay, but also how that...

How ‘Cool’ Science Translates Into Successful Companies – A Chat with UNITY Biotechnology CEO, Nathaniel David

By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) “Basically everything I work on has to be cool. That’s the common thread. People look at that and say, ‘Dude, that’s cool.’ That’s the honest to goodness truth.  I will continue to work on...

An Insider’s Perspective on European Biotech Venture Investment – A Chat with Sander Slootweg, Managing Partner and Co-Founder of Forbion Capital Partners

By Hui Cai, Vice President of Corporate Alliances and Head of Communications, WuXi AppTec “Since the late 1990’s there’s been a lot of change on the VC side in Europe. Those players that are still here have weathered the adverse market conditions of the past....

Inside Perspectives on Immunotherapy: An Interview with Advaxis CEO Daniel O’Connor

Advaxis Immunotherapies, led by President and CEO Daniel O’Connor, is developing a promising and versatile approach to immuno-oncology with its Listeria monocytogenes (Lm) antigen delivery system. Lm Technology™ shows the immune system how to identify and target tumors, weakens tumor defense mechanisms, and triggers...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm...

Toronto-based Cyclica President and CEO Naheed Kurji acknowledges that artificial intelligence (AI) is a transformative technology, but he contends it is not the “silver...